RXII has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
RXII has been removed from your Stock Email Alerts list.
| Company | RXi Pharmaceuticals Corp (RXII) | () |
| Number of Guru Holders | ||
| Combined Weightings (%) | ||
| Number of Guru Buys:Sells (3 months) | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (6 months) | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (12 months) | 0 : 0 | 0 : 0 |
| Number of Insider Buys (3 months) | 0 | |
| Industry | ||
| Price ($) | 0.20 | |
| Market Value ($mil) | 63.04 | |
| Revenue ($mil) | 0.10 | |
| P/E(ttm) | 0 | |
| P/S | 285.71 | |
| P/B | 0 | |
| Yield (%) | 0 | |
| Payout | 0 | |
| ROA (%) | -230.30 | |
| ROE (%) | 0 | |
| Operating Margin (%) | -13,376.30 | |
| Net Margin (%) | -13,278.40 | |
| Debt to Equity (%) | 0 | |
| 10-Year Rvn. Growth (%) | 0 | |
| 10-Year Earning Growth (%) | 0 | |
| 5-Year Rvn. Growth (%) | 0 | |
| 5-Year Earning Growth (%) | 0 | |
| 1-Year Rvn. Growth (%) | 0 | |
| 1-Year Earning Growth (%) | 0 |